
BIOPHEN™ DiXaI — dviejų etapų anti-Xa metodas, skirtas tiesioginiams Xa inhibitoriams
Kaina:$440,00
Produkto aprašymasSkirta tik moksliniams tyrimams. Nenaudoti diagnostikos procedūrose. Two-stage chromogenic anti-Xa method specifically designed for the quantitative measurement of direct Factor Xa inhibitors (DiXaIs) in citrated human plasma: Rivaroxaban (Xarelto®), Apixaban (Eliquis®), and Edoxaban (Lixiana®). Important: This method is NOT suitable for indirect inhibitors such as heparins or Fondaparinux. Use BIOPHEN™ Heparin LRT (ref. 221011/221013/221015) for those analytes.
Produkto charakteristikos
Produkto sudedamosios dalys
|
Produkto pritaikymo sritys
For the measurement of Rivaroxaban, Apixaban, and other direct Factor Xa inhibitors in research applications.
Naudojimo instrukcijosDuomenų lapas / Techniniai duomenysAnalizės sertifikatas (COA) |